Our Pipeline


Juno is focused on partnering with leading biologic and biosimilar manufacturers, to increase patient access to these lifesaving and life changing medicines in Australia and New Zealand.

There are a number of opportunities across multiple therapeutic areas we are advancing in the near term, which will be made public once finalised.

We are also actively looking for new ways to bring value to the Australian and New Zealand healthcare systems and seeking new partnerships and opportunities. We believe our expertise makes us well suited to launching new biosimilars and interchangeable biologic products in Australia and New Zealand, loss of exclusivity (LOE) management for established brands and consulting on the biologic and biosimilar market landscape in Australia and New Zealand.

Contact us if you wish to discuss a partnership.